Stay updated on CVL-865 Adjunctive Therapy in Focal Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the CVL-865 Adjunctive Therapy in Focal Onset Seizures Clinical Trial page.

Latest updates to the CVL-865 Adjunctive Therapy in Focal Onset Seizures Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check16 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has updated the details of an Open-label Extension Trial of CVL-865, changing the sponsor from Cerevel Therapeutics, LLC to AbbVie and updating the trial date from March 25, 2025, to April 4, 2025.SummaryDifference3%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
Stay in the know with updates to CVL-865 Adjunctive Therapy in Focal Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-865 Adjunctive Therapy in Focal Onset Seizures Clinical Trial page.